ADIPOQ and coronary artery disorder: While the mechanisms by which adiponectin and CAD interact with each other remain elusive, multiple associations with echocardiographic parameters that are significant after adjustment for clinical factors suggest that adiponectin is a good candidate as a marker to improve the monitoring of cardiac remodelling and dysfunction in CAD patients.